SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Zhiling Zhang, Zhicheng Wang, Jia Nong, Camilla A Nix, Hai-Feng Ji, Yinghui Zhong, Metal ion-assisted self-assembly of complexes for controlled and sustained release of minocycline for biomedical applications, Biofabrication, 2015, 7, 1, 015006

    CrossRef

  2. 2
    Sapna P. Sadarangani, Lynn L. Estes, James M. Steckelberg, Non–anti-infective Effects of Antimicrobials and Their Clinical Applications, Mayo Clinic Proceedings, 2015, 90, 1, 109

    CrossRef

  3. 3
    Yossi Rosman, Merav Lidar, Yehuda Shoenfeld, Antibiotic therapy in autoimmune disorders, Clinical Practice, 2014, 11, 1, 91

    CrossRef

  4. 4
    Mesut Ogrendik, Oral Bacteria Are Responsible for the Etiology of Rheumatoid Arthritis, Open Journal of Rheumatology and Autoimmune Diseases, 2014, 04, 03, 162

    CrossRef

  5. 5
    Christopher Chang, Unmet needs in the treatment of autoimmunity: From aspirin to stem cells, Autoimmunity Reviews, 2014, 13, 4-5, 331

    CrossRef

  6. 6
    Brygida Kwiatkowska, Maria Maslinska, Malgorzata Przygodzka, Joanna Dmowska-Chalaba, Justyna Dabrowska, Katarzyna Sikorska-Siudek, Immune system as a new therapeutic target for antibiotics, Advances in Bioscience and Biotechnology, 2013, 04, 04, 91

    CrossRef

  7. 7
    James R. O'Dell, Kelley's Textbook of Rheumatology, 2013,

    CrossRef

  8. 8
    Christopher J Smith, Harlan Sayles, Ted R Mikuls, Kaleb Michaud, Minocycline and doxycycline therapy in community patients with rheumatoid arthritis: prescribing patterns, patient-level determinants of use, and patient-reported side effects, Arthritis Research & Therapy, 2011, 13, 5, R168

    CrossRef

  9. 9
    R.G. Agrawal, A. Hewetson, C.M. George, P.J. Syapin, S.E. Bergeson, Minocycline reduces ethanol drinking, Brain, Behavior, and Immunity, 2011, 25, S165

    CrossRef

  10. 10
    Angela Smith, Caroline Doré, Peter Charles, Alena Vallance, Tara Potier, Charles Mackworth-Young, Randomised Double-Blind Trial of Combination Antibiotic Therapy in Rheumatoid Arthritis, International Journal of Rheumatology, 2011, 2011, 1

    CrossRef

  11. 11
    Mesut Ogrendik, Nihan Karagoz, Treatment of Rheumatoid Arthritis with Roxithromycin: A Randomized Trial, Postgraduate Medicine, 2011, 123, 5, 220

    CrossRef

  12. 12
    Mohamed M. Thabet, Tom W.J. Huizinga, Rheumatology, 2011,

    CrossRef

  13. 13
    Pamela Mangat, Natalia Wegner, Patrick J Venables, Jan Potempa, Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis?, Arthritis Research & Therapy, 2010, 12, 3, 209

    CrossRef

  14. 14
    Mesut Ogrendik, Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: A 3-month, randomized, double-blind, placebo-controlled trial, Clinical Therapeutics, 2009, 31, 8, 1754

    CrossRef

  15. 15
    Alejandro Díaz-Borjón, Guidelines for the Use of Conventional and Newer Disease-Modifying Antirheumatic Drugs in Elderly Patients with Rheumatoid Arthritis, Drugs & Aging, 2009, 26, 4, 273

    CrossRef

  16. 16
    Mesut Ogrendik, Rheumatoid arthritis is linked to oral bacteria: etiological association, Modern Rheumatology, 2009, 19, 5, 453

    CrossRef

  17. 17
    Mesut Ogrendik, Rheumatoid arthritis is linked to oral bacteria: etiological association, Modern Rheumatology, 2009, 19, 5, 453

    CrossRef

  18. 18
    Suzan M. ATTAR, Tetracyclines: what a rheumatologist needs to know?, International Journal of Rheumatic Diseases, 2009, 12, 2
  19. 19
    Kenneth G. Saag, Gim Gee Teng, Nivedita M. Patkar, Jeremy Anuntiyo, Catherine Finney, Jeffrey R. Curtis, Harold E. Paulus, Amy Mudano, Maria Pisu, Mary Elkins-Melton, Ryan Outman, Jeroan J. Allison, Maria Suarez Almazor, S. Louis Bridges, W. Winn Chatham, Marc Hochberg, Catherine Maclean, Ted Mikuls, Larry W. Moreland, James O'dell, Anthony M. Turkiewicz, Daniel E. Furst, American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis, Arthritis Care & Research, 2008, 59, 6
  20. 20
    Brian T. Fay, Annemarie P. Whiddon, Susan Puumala, Natalie A. Black, James R. OʼDell, Ted R. Mikuls, Minocycline-Induced Hyperpigmentation in Rheumatoid Arthritis, JCR: Journal of Clinical Rheumatology, 2008, 14, 1, 17

    CrossRef

  21. 21
    André L. Pataro, Michele F. Oliveira, Karina I.R. Teixeira, Regina M.M. Turchetti-Maia, Miriam T.P. Lopes, Francisco H.L. Wykrota, Rubén D. Sinisterra, Maria E. Cortés, Polymer: Bioceramic composites optimization by tetracycline addition, International Journal of Pharmaceutics, 2007, 336, 1, 75

    CrossRef

  22. 22
    K. Vandevyvere, F. P. Luyten, P. Verschueren, R. Lories, S. Segaert, R. Westhovens, Pyoderma gangrenosum developing during therapy with TNF-alpha antagonists in a patient with rheumatoid arthritis, Clinical Rheumatology, 2007, 26, 12, 2205

    CrossRef

  23. 23
    Graciela S Alarcón, Early rheumatoid arthritis: combination therapy of doxycycline plus methotrexate versus methotrexate monotherapy, Nature Clinical Practice Rheumatology, 2006, 2, 6, 296

    CrossRef

  24. 24
    Allen N. Sapadin, Raul Fleischmajer, Tetracyclines: Nonantibiotic properties and their clinical implications, Journal of the American Academy of Dermatology, 2006, 54, 2, 258

    CrossRef

  25. 25
    James R. O'Dell, Jennifer R. Elliott, Jack A. Mallek, Ted R. Mikuls, Cynthia A. Weaver, Scott Glickstein, Kent M. Blakely, Raymond Hausch, Rob D. Leff, Treatment of early seropositive rheumatoid arthritis: Doxycycline plus methotrexate versus methotrexate alone, Arthritis & Rheumatism, 2006, 54, 2
  26. 26
    Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions, 2006,

    CrossRef

  27. 27
    Karen H. Costenbader, Jonathan S. Coblyn, Statin Therapy in Rheumatoid Arthritis, Southern Medical Journal, 2005, 98, 5, 534

    CrossRef

  28. 28
    Alastair J.J. Wood, James R. O'Dell, Therapeutic Strategies for Rheumatoid Arthritis, New England Journal of Medicine, 2004, 350, 25, 2591

    CrossRef

  29. 29
    David W McCarey, Iain B McInnes, Rajan Madhok, Rosie Hampson, Olga Scherbakova, Ian Ford, Hilary A Capell, Naveed Sattar, Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial, The Lancet, 2004, 363, 9426, 2015

    CrossRef

  30. 30
    T. Midtvedt, 2003,

    CrossRef

  31. 31
    Jennifer Hamilton, Vadivelu Saravanan, Advances in the treatment of rheumatoid arthritis: old versus new therapies, Expert Opinion on Pharmacotherapy, 2002, 3, 7, 845

    CrossRef

  32. 32
    Guidelines for the management of rheumatoid arthritis: 2002 Update , Arthritis & Rheumatism, 2002, 46, 2
  33. 33
    James R. O'Dell, COMBINATIONS OF CONVENTIONAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS, Rheumatic Disease Clinics of North America, 2001, 27, 2, 415

    CrossRef

  34. 34
    James R. O'Dell, How is it best to treat early rheumatoid arthritis patients?, Best Practice & Research Clinical Rheumatology, 2001, 15, 1, 125

    CrossRef

  35. 35
    Johanne Martel-Pelletier, Dean J. Welsch, Jean-Pierre Pelletier, Metalloproteases and inhibitors in arthritic diseases, Best Practice & Research Clinical Rheumatology, 2001, 15, 5, 805

    CrossRef

  36. 36
    John P. Case, Old and New Drugs Used in Rheumatoid Arthritis: A Historical Perspective, American Journal of Therapeutics, 2001, 8, 3, 163

    CrossRef

  37. 37
    Larry W. Moreland, POTENTIAL BIOLOGIC AGENTS FOR TREATING RHEUMATOID ARTHRITIS, Rheumatic Disease Clinics of North America, 2001, 27, 2, 445

    CrossRef

  38. 38
    E. William St.Clair, William E. Wilkinson, David S. Pisetsky, Daniel J. Sexton, Richard Drew, Virginia B. Kraus, Robert A. Greenwald, The effects of intravenous doxycycline therapy for rheumatoid arthritis: A randomized, double-blind, placebo-controlled trial, Arthritis & Rheumatism, 2001, 44, 5
  39. 39
    James R. O'Dell, Kent W. Blakely, Jack A. Mallek, P. James Eckhoff, Rob D. Leff, Steven J. Wees, Kelly M. Sems, Ana M. Fernandez, William R. Palmer, Lynell W. Klassen, Gail A. Paulsen, Claire E. Haire, Gerald F. Moore, Treatment of early seropositive rheumatoid arthritis: A two-year, double-blind comparison of minocycline and hydroxychloroquine, Arthritis & Rheumatism, 2001, 44, 10
  40. 40
    Charles W. Stratton, Association of Chlamydia pneumoniae with chronic human diseases, Antimicrobics and Infectious Diseases Newsletter, 2000, 18, 7, 49

    CrossRef

  41. 41
    Pnina Langevitz, Avi Livneh, Ilan Bank, Mordechai Pras, Benefits and Risks of Minocycline in Rheumatoid Arthritis, Drug Safety, 2000, 22, 5, 405

    CrossRef

  42. 42
    Graciela S Alarcón, Tetracyclines for the treatment of rheumatoid arthritis, Expert Opinion on Investigational Drugs, 2000, 9, 7, 1491

    CrossRef

  43. 43
    Kimberly Hamilton, E William St. Clair, Tumour necrosis factor-α blockade: a new era for effective management of rheumatoid arthritis, Expert Opinion on Pharmacotherapy, 2000, 1, 5, 1041

    CrossRef

  44. 44
    Carin E. Dugowson, Women and Health, 2000,

    CrossRef

  45. 45
    Leonard H. Sigal, ANTIBIOTICS FOR THE TREATMENT OF RHEUMATOLOGIC SYNDROMES, Rheumatic Disease Clinics of North America, 1999, 25, 4, 861

    CrossRef

  46. 46
    Andrew H. Eichenfield, Minocycline and autoimmunity, Current Opinion in Pediatrics, 1999, 11, 5, 447

    CrossRef

  47. 47
    R Madhok, HA Capell, Outstanding issues in use of disease–modifying agents in rheumatoid arthritis, The Lancet, 1999, 353, 9149, 257

    CrossRef

  48. 48
    Shigehisa Aoki, Rheumatoid arthritis and enteric bacteria, Japanese Journal of Rheumatology, 1999, 9, 4, 325

    CrossRef

  49. 49
    KARI K. EKLUND, TIMO SORSA, Tetracycline Derivative CMT-3 Inhibits Cytokine Production, Degranulation, and Proliferation in Cultured Mouse and Human Mast Cells, Annals of the New York Academy of Sciences, 1999, 878, 1
  50. 50
    Alisa E. Koch, Angiogenesis: Implications for rheumatoid arthritis, Arthritis & Rheumatism, 1998, 41, 6
  51. 51
    Juan M. Angulo, Leonard H. Sigal, Luis R. Espinoza, Coexistent minocycline-induced systemic lupuserythematosus and autoimmune hepatitis, Seminars in Arthritis and Rheumatism, 1998, 28, 3, 187

    CrossRef

  52. 52
    Graciela S. Alarcón, MINOCYCLINE FOR THE TREATMENT OF RHEUMATOID ARTHRITIS, Rheumatic Disease Clinics of North America, 1998, 24, 3, 489

    CrossRef

  53. 53
    Bridget Griffiths, Andy Gough, Paul Emery, Minocycline-induced autoimmune disease: Comment on the editorial by Breedveld, Arthritis & Rheumatism, 1998, 41, 3
  54. 54
    Marjatta Leirisalo-Repo, PROGNOSIS, COURSE OF DISEASE, AND TREATMENT OF THE SPONDYLOARTHROPATHIES, Rheumatic Disease Clinics of North America, 1998, 24, 4, 737

    CrossRef

  55. 55
    WILLIAM H. BOWLES, Protection against Minocycline Pigment Formation by Ascorbic Acid (Vitamin C), Journal of Esthetic and Restorative Dentistry, 1998, 10, 4
  56. 56
    Ferdinand C. Breedveld, Reply, Arthritis & Rheumatism, 1998, 41, 3
  57. 57
    James R. O'Dell, TRIPLE THERAPY WITH METHOTREXATE, SULFASALAZINE, AND HYDROXYCHLOROQUINE IN PATIENTS WITH RHEUMATOID ARTHRITIS, Rheumatic Disease Clinics of North America, 1998, 24, 3, 465

    CrossRef

  58. 58
    I. C. CHIKANZA, S. JAWED, D. NAUGHTON, D. R. BLAKE, Why Do We Need New Treatments for Rheumatoid Arthritis?, Journal of Pharmacy and Pharmacology, 1998, 50, 4
  59. 59
    Larry W. Moreland, Louis W. Heck, William J. Koopman, Biologic agents for treating rheumatoid arthritis. Concepts and progress, Arthritis & Rheumatism, 1997, 40, 3
  60. 60
    Michael Schiff, Emerging treatments for rheumatoid arthritis, The American Journal of Medicine, 1997, 102, 1, 11S

    CrossRef

  61. 61
    Ferdinand C. Breedveld, Minocycline IN RHEUMATOID ARTHRITIS, Arthritis & Rheumatism, 1997, 40, 5
  62. 62
    Robert W. Hoffman, Frank X. O'Sullivan, Kim R. Schafermeyer, Terry L. Moore, Deborah Roussell, Robyn Watson-McKown, Mary F. Kim, Kim S. Wise, Mycoplasma infection and rheumatoid arthritis: Analysis of their relationship using immunoblotting and an ultrasensitive polymerase chain reaction detection method, Arthritis & Rheumatism, 1997, 40, 7, 1219

    CrossRef

  63. 63
    Robert W. Hoffman, Frank X. O'Sullivan, Kim R. Schafermeyer, Terry L. Moore, Deborah Roussell, Robyn Watson-Mckown, Mary F. Kim, Kim S. Wise, Mycoplasma infection and rheumatoid arthritis. Analysis of their relationship using immunoblotting and an ultrasensitive polymerase chain reaction detection method, Arthritis & Rheumatism, 1997, 40, 7
  64. 64
    D. N. Leitch, D. I. Haslock, Psoriatic arthritis and minocycline induced autoantibodies, Clinical Rheumatology, 1997, 16, 3, 317

    CrossRef

  65. 65
    James R. O'Dell, Claire E. Haire, William Palmer, Walter Drymalski, Steven Wees, Kent Blakely, Melvin Churchill, P. James Eckhoff, Arthur Weaver, Deborah Doud, Nils Erikson, Fred Dietz, Rich Olson, Pierre Maloley, Lynell W. Klassen, Gerald F. Moore, Treatment of early Rheumatoid Arthritis with minocycline or placebo. Results of a Randomized, double-blind, placebo-controlled trial, Arthritis & Rheumatism, 1997, 40, 5
  66. 66
    Rita Jain, Peter E. Lipsky, TREATMENT OF RHEUMATOID ARTHRITIS, Medical Clinics of North America, 1997, 81, 1, 57

    CrossRef

  67. 67
    D. Nordström, O. Lindy, Y. T. Konttinen, A. Lauhio, T. Sorsa, C. Friman, T. Pettersson, S. Santavirta, Cathepsin G and elastase in synovial fluid and peripheral blood in reactive and rheumatoid arthritis, Clinical Rheumatology, 1996, 15, 1, 35

    CrossRef

  68. 68
    Marie Thérèse Labro, Immunomodulatory Actions of Antibacterial Agents, Clinical Immunotherapeutics, 1996, 6, 6, 454

    CrossRef

  69. 69
    Margreet Kloppenburg, Ben A.C. Dijkmans, Cor L. Verweij, Ferdinand C. Breedveld, Inflammatory and immunological parameters of disease activity in rheumatoid arthritis patients treated with minocycline, Immunopharmacology, 1996, 31, 2-3, 163

    CrossRef

  70. 70
    A. Weinberger, T. Ben-Gal, P. Roizman, A. Abramovici, Intraarticular minocycline injection in experimental synovitis, Clinical Rheumatology, 1996, 15, 3, 290

    CrossRef

  71. 71
    Margreet Kloppenburg, Ferdinand C. Breedveld, Ben A. C. Dijkmans, Minocycline in Rheumatoid Arthritis, Clinical Immunotherapeutics, 1996, 5, 1, 1

    CrossRef

  72. 72
    Gideon Nesher, Terry L. Moore, Recommendations for Drug Therapy of Rheumatoid Arthritis in Elderly Patients, Clinical Immunotherapeutics, 1996, 5, 5, 341

    CrossRef

  73. 73
    William S. Wilke, Joseph M. Cash, The Use of Slower-Acting (Class III) Symptom-Modifying Antirheumatic Drugs in Rheumatoid Arthritis, Clinical Immunotherapeutics, 1996, 5, 4, 309

    CrossRef

  74. 74
    M. Kloppenburg, B.A.C. Dijkmans, F.C. Breedveld, Antimicrobial therapy for rheumatoid arthritis, Baillière's Clinical Rheumatology, 1995, 9, 4, 759

    CrossRef

  75. 75
    Theresa Podrebarac, Robert McKendry, Cellular suicide: Critical concept or fleeting fad?, The Lancet, 1995, 346, S22

    CrossRef

  76. 76
    RobertJ.R. McKendry, Is rheumatoid arthritis caused by an infection?, The Lancet, 1995, 345, 8961, 1319

    CrossRef

  77. You have free access to this content77
    M. KLOPPENBURG, C. L. VERWEIJ, A. M. M. MILTENBURG, A. J. VERHOEVEN, M. R. DAHA, B. A. C. DIJKMANS, F. C. BREEDVELD, The influence of tetracyclines on T cell activation, Clinical & Experimental Immunology, 1995, 102, 3
  78. 78
    M. KLOPPENBURG, J. PH. TERWIEL, C. MALLÉE, F. C. BREEDVELD, B. A. C. DIJKMANS, Minocycline in Active Rheumatoid Arthritis, Annals of the New York Academy of Sciences, 1994, 732, 1